Searched for
INTEGRAL BIOSCIENCES
Ashoka University appoints Professor Rishikesha T. Krishnan as its next vice-chancellorAshoka University has appointed Professor Rishikesha T. Krishnan as its next Vice-Chancellor, effective August 1, 2026. A distinguished sch...- Intel CEO unveils AI innovations and partnerships at mega tech event in TaiwanIntel unveiled new AI-focused technologies, strategic collaborations, and next-generation processors at Computex 2026. The company announce...
- Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical researchIIT Roorkee has launched the Ashok Soota Molecular Medicine Facility, a state-of-the-art platform for advanced biomedical research, drug di...
- Anthem Biosciences IPO: What GMP signals ahead of listing on MondayAnthem Biosciences will debut on stock exchanges on Monday, July 21, with grey market signals suggesting a potential 29% listing gain over ...
- Anthem Biosciences IPO subscribed 4x on last day; Check GMP, and other key detailsAnthem Biosciences IPO GMP: The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non...
- Anthem Biosciences IPO subscribed 2x on day 2; Check GMP, and other key detailsAnthem Biosciences' IPO witnessed strong investor interest, being oversubscribed 2.08 times on Day 2, driven by NIIs. Brokerages recommend ...
- Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14Anthem Biosciences' Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CR...
- Sensex rises! These stocks rallied over 15% on BSE in today's tradeIn the Nifty50 index, 27 stocks closed in the green, while 23 stocks ended in the red.
- Anthem Biosciences appoints JM Financial, Citi, JP Morgan as bankers for IPOAnthem Biosciences has selected JM Financial as the lead banker for its IPO, along with Citi and JP Morgan. The company plans to raise Rs 3...
- Alkem subsidiary Enzene launches adalimumab biosimilar in IndiaEnzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.
- CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DGThe CSIR-Indian Institute of Chemical Technology (IICT) here and Bengaluru-based Anthem Biosciences Pvt Ltd have entered into an agreement ...
- Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7,300-crore valuationThe other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.
- Private equity fund True North acquires minority stake in Bengaluru-based Anthem BioSet up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderab...
- True North set to buy 8-10% stake in Anthem for Rs 740 crTrue North will acquire about 8-10 per cent stake in Anthem Biosciences for Rs 740 crore ($75-100 million), at a valuation of $1 billion (R...
- Studying the structure of coronavirus will help discovery of vaccineStudying the structure of the coronavirus will help the discovery of a vaccine, leading national and international therapeutics, who are tr...
- Swedish pharma firm Medivir partners GVK Bio for drug researchThis is the first pact the city-based clinical research the company has inked after it got involved in regulatory issues with European Medi...
- GVK Biosciences to buy Chennai based Vanta Bio for $5millionVanta Bio is into offering toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries.
- GVK BIO signs pact with US-based Aragen Bioscience Inc for acquisitionGVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...
Load More
